Price Indices of Drugs and the Switching to New Drugs: Two Empirical Examples

Author： Gerdtham U-G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.1 Part 2, 1998-01, pp. : 71-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From QSAR models of Drugs to Complex Networks: State-of-Art Review and Introduction of New Markov-Spectral Moments Indices

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 8, 2012-04 ,pp. : 927-960

Bentham Science Publishers

Access to resources Recommend Favorite

A Computer-Based Approach to the Rational Discovery of New Trichomonacidal Drugs by Atom-Type Linear Indices

By  

Current Drug Discovery Technologies, Vol. 2, Iss. 4, 2005-12 ,pp. : 245-265

Bentham Science Publishers

Access to resources Recommend Favorite

The pros and cons of Rx-to-OTC switching of drugs in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The pros and cons of Rx-to-OTC switching of drugs in the US

By  

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

New Targets for Antithrombotic Drugs

By Thiagarajan P.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 227-235

Adis International

Access to resources Recommend Favorite